Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps.
Mitra S, Ring AM, Amarnath S, Spangler JB, Li P, Ju W, Fischer S, Oh J, Spolski R, Weiskopf K, Kohrt H, Foley JE, Rajagopalan S, Long EO, Fowler DH, Waldmann TA, Garcia KC, Leonard WJ.
Mitra S, et al. Among authors: oh j.
Immunity. 2015 May 19;42(5):826-38. doi: 10.1016/j.immuni.2015.04.018.
Immunity. 2015.
PMID: 25992859
Free PMC article.